Molecular Imaging in the Era of Personalized Medicine.
- Author:
Kyung Ho JUNG
1
;
Kyung Han LEE
Author Information
- Publication Type:Review
- Keywords: Molecular imaging; Individualized medicine; Receptor; Angiogenesis; Apoptosis
- MeSH: Apoptosis; Biochemical Processes; Biomarkers; Cardiovascular Diseases; Diagnosis; Precision Medicine*; Molecular Biology; Molecular Imaging*; Pathology
- From:Journal of Pathology and Translational Medicine 2015;49(1):5-12
- CountryRepublic of Korea
- Language:English
- Abstract: Clinical imaging creates visual representations of the body interior for disease assessment. The role of clinical imaging significantly overlaps with that of pathology, and diagnostic workflows largely depend on both fields. The field of clinical imaging is presently undergoing a radical change through the emergence of a new field called molecular imaging. This new technology, which lies at the intersection between imaging and molecular biology, enables noninvasive visualization of biochemical processes at the molecular level within living bodies. Molecular imaging differs from traditional anatomical imaging in that biomarkers known as imaging probes are used to visualize target molecules-of-interest. This ability opens up exciting new possibilities for applications in oncologic, neurological and cardiovascular diseases. Molecular imaging is expected to make major contributions to personalized medicine by allowing earlier diagnosis and predicting treatment response. The technique is also making a huge impact on pharmaceutical development by optimizing preclinical and clinical tests for new drug candidates. This review will describe the basic principles of molecular imaging and will briefly touch on three examples (from an immense list of new techniques) that may contribute to personalized medicine: receptor imaging, angiogenesis imaging, and apoptosis imaging.
